Earnings Preview: Deciphera Pharmaceuticals
Portfolio Pulse from Benzinga Insights
Deciphera Pharmaceuticals (NASDAQ:DCPH) is set to release its latest quarterly earnings report on August 9, 2023. Analysts estimate an earnings per share (EPS) of $-0.62. The company's past performance shows a trend of missing EPS estimates and subsequent drops in share price. The stock is currently trading at $12.82, down 25.47% over the last 52-week period.
August 08, 2023 | 3:02 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Deciphera Pharmaceuticals is expected to report an EPS of $-0.62. The company's history of missing EPS estimates and subsequent share price drops could potentially impact the stock negatively.
Deciphera Pharmaceuticals has a history of missing EPS estimates, which has typically resulted in a drop in share price. Given this trend and the current analyst estimate of $-0.62, there is a potential for negative impact on the stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100